ESMO Asia 2017 Congress: ESMO Colloquia

The ESMO Colloquia are innovative new sessions within the Congress programme that bring together top experts to discuss evolving areas of interest to the oncology community. 

The Colloquia are organised by ESMO and supported by the industry in a unique collaboration making them the perfect complement to the scientific and education programme of the congress.

Saturday, 18 November 2017

ESMO Colloquium: Selection criteria for the treatment of castration-resistant prostate cancer (CRPC)

Selection Criteria for the Treatment of Castration Resistant Prostate Cancer CRPC - Thumb

Room 325, 12:45 – 14:15
This educational activity is provided by ESMO and supported by Astellas.
View the ESMO colloquium details

Learning Objectives

  1. Understand and optimise the use of available treatment
  2. Select the best treatment according to clinical presentation
  3. Consider tolerance profile and patient preferences

Sunday, 19 November 2017

ESMO Colloquium: The incoming wave of Oncology Biosimilars, in Asia

The Incoming Wave of Oncology Biosimilars in Asia - thumb

Hall 404, 11:00 – 12:30
This educational activity is provided by ESMO and supported by Amgen, Pfizer, Roche and Sandoz 
View the ESMO colloquium details

Learning Objectives

  1. Understand the complexities and nuances of developing biosimilar medicinal products in the Asia-Pacific region
  2. Educate the Asia-Pacific community, especially prescribers, on biosimilar medical products in the field of oncology
  3. Assess the financial impact of biosimilar medicinal products in the Asia-Pacific region
  4. Discuss potential challenges the oncology community, including patients, may face and the possible solutions